tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Kura Oncology (KURA)
NASDAQ:KURA
US Market
KURA
Kura Oncology
Overview
Analyst Forecasts
AI Stock Analysis
News & Insights
Financials
Dividends
Technical Analysis
Options
Chart
Earnings
Ownership
Historical Prices
Stock Buybacks
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Kura Oncology (KURA) Stock News & Sentiment

Compare
591 Followers
Kura Oncology’s Financial Future at Risk: Dependency on Kyowa Kirin for Ziftomenib Development Raises Concerns
Premium
Company Announcements
Kura Oncology’s Financial Future at Risk: Dependency on Kyowa Kirin for Ziftomenib Development Raises Concerns
27d ago
KURA
Kura Oncology’s Positive Earnings Call Highlights Progress and Prospects
Premium
Company Announcements
Kura Oncology’s Positive Earnings Call Highlights Progress and Prospects
29d ago
KURA
Kura Oncology: Strong Financials and Promising Clinical Developments Drive Buy Rating
Premium
Ratings
Kura Oncology: Strong Financials and Promising Clinical Developments Drive Buy Rating
30d ago
KURA
Bullish Outlook for Kura Oncology: Buy Rating Affirmed Amid Optimism for Ziftomenib Approval and Competitive Advantage
Premium
Ratings
Bullish Outlook for Kura Oncology: Buy Rating Affirmed Amid Optimism for Ziftomenib Approval and Competitive Advantage
30d ago
KURA
Kura Oncology’s Promising Pipeline and Strategic Focus Justify Buy Rating
Premium
Ratings
Kura Oncology’s Promising Pipeline and Strategic Focus Justify Buy Rating
30d ago
KURA
Kura Oncology Advances Cancer Drug Development
Premium
Company Announcements
Kura Oncology Advances Cancer Drug Development
30d ago
KURA
Kura Oncology’s Promising Path to FDA Approval: Analyst Recommends ‘Buy’ Following Positive Phase II Results and Strategic Advancements
Premium
Ratings
Kura Oncology’s Promising Path to FDA Approval: Analyst Recommends ‘Buy’ Following Positive Phase II Results and Strategic Advancements
30d ago
KURA
More KURA News >

KURA News on the Web

Insider Sell: Faheem Hasnain Sells 22,682 Shares of Kura Oncology Inc (KURA)
GuruFocus News
Neutral
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635
Yahoo Finance
Neutral
Analysts Are Bullish on Top Healthcare Stocks: HCA Healthcare (HCA), Kura Oncology (KURA)
TipRanks News
Neutral
Kura Oncology’s Financial Future at Risk: Dependency on Kyowa Kirin for Ziftomenib Development Raises Concerns
TipRanks News
Neutral
Kura Oncology shareholders have endured a 64% loss from investing in the stock a year ago
Yahoo Finance
Neutral
Kura Oncology’s Positive Earnings Call Highlights Progress and Prospects
TipRanks News
Neutral
Q4 2024 Kura Oncology Inc Earnings Call
Yahoo Finance
Neutral
Kura Oncology Inc Q4 2024 Earnings Call Highlights: Strategic Advances and Financial Growth
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
KURA
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average60%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is KURA’s Media Buzz Sentiment?
1 articles about KURA were published this week. In an average week, 1 articles are published.
    What is KURA’s weekly average amount of articles?
    In an average week, 1 articles about KURA are published.
      What is KURA’s News Sentiment?
      50% of articles about KURA were positive this week, compared to its sector average of 60%.
        Healthcare Stocks that are Trending in the News
        ALCAlcon
        SLNOSoleno Therapeutics
        DYAIDyadic International
        ASMBAssembly Biosciences
        CLGNCollplant Holdings
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing